Craft

Dextera Surgical

Stock Price

$0.2

2017-10-31

Market Capitalization

$7.5 M

2017-10-31

Revenue

$2.5 B

FY, 2016

Dextera Surgical Summary

Company Summary

Overview
Dextera Surgical Inc. provides technologies designed to enable surgeons to improve patient outcomes. Dextera is commercializing and developing its MicroCutter 5/80 stapler based on proprietary “staple-on-a-strip” technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons. The MicroCutter 5/80 may reduce the amount of dissection and tissue handling required to position the stapler in confined spaces, enabling access to difficult-to-reach anatomy. The cartridge-based device’s small size and wide articulation range is designed to enhance the surgeon’s access and visualization at the surgical site, and to mitigate limitations on the advancement of minimally invasive surgical approaches created by larger stapling devices.
Type
Public
Status
Closed
Founded
1997
HQ
Redwood City, CA, US | view all locations
Website
https://www.dexterasurgical.com/
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Redwood City, CA HQ

    United States

    900 Saginaw Dr

Dextera Surgical Financials

Summary Financials

Revenue (FY, 2016)
$2.5B
Gross profit (FY, 2016)
($1.4B)
Net income (FY, 2016)
($16.0M)
Cash (FY, 2016)
$3.6M
EBIT (FY, 2016)
($15.6B)

Footer menu